
Tian Zhang, M.D.
Titles and Appointments
Associate Professor
- School
- Medical School
- Department
- Internal Medicine
You have reached the Academic Profile.
For more information on the doctor and patient care, please visit the clinical profile.
Tian Zhang, M.D., M.H.S., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology.
Dr. Zhang earned her medical degree from the Harvard-MIT Health Sciences and Technology program at Harvard Medical School. She completed a residency in internal medicine at Duke University in North Carolina, where she also received advanced training through a hematology-oncology fellowship. In addition, she earned a Master of Health Sciences in the Clinical Research Training Program at Duke.
Certified by the American Board of Internal Medicine in medical oncology, she joined the UT Southwestern faculty in 2021.
Dr. Zhang was appointed Associate Director of Clinical Research in the Simmons Comprehensive Cancer Center in May 2024. She also serves as Director of Clinical Research within the Division of Hematology and Oncology in the Department of Internal Medicine. She is an accomplished clinical trialist and translational researcher focused on evaluating the clinical development of novel therapeutics and evaluating biomarkers for genitourinary malignancies. She partners closely with a multidisciplinary team at UT Southwestern to provide data-driven clinical care for her patients. She specializes in the diagnosis and treatment of genitourinary malignancies, including kidney, prostate, bladder, and testicular cancers.
Dr. Zhang is a member of several professional organizations, including the American Society of Clinical Oncology, the American Association for Cancer Research, European Society for Medical Oncology, the Society for Immunotherapy of Cancer (SITC) and the Chinese American Hematology and Oncology Network (CAHON).
Dr. Zhang serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary Steering Committee Renal Task Force. She is a member of several ASCO and SITC clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology GU Oncology, and Immuno-Oncology Committees.
She brings a track record of research and mentoring to UT Southwestern. She has received multiple peer-reviewed grants, including notably, the 2021 Cancer Prevention & Research Institute of Texas Scholar Rising Stars Award. She is co-PI on several DOD and NCI funded grants. Her laboratory focuses on correlative and biomarker studies for patients with GU cancers.